Roger Frank
Well-known member
Heart-valve illness studied
The Press
Last updated 05:00 17/03/2009
Christchurch medics are shedding new light on a deadly heart condition that kills up to 40 per cent of sufferers within a year.
Endocarditis is an infection of the heart valve that requires hospitalisation, intravenous antibiotics and, in severe cases, replacement of the infected heart valve.
In Canterbury, there are about 30 new patients with endocarditis each year and an estimated 300 across New Zealand.
However, lead investigator, Professor David Murdoch, of the University of Otago, Christchurch, said mortality rates were lower in New Zealand.
Globally, 18 per cent of people die from endocarditis in hospital and up to 40 per cent will die within a year.
There are also risks of ongoing complications such as stroke, blood clots and heart failure.
The five-year study examined the presentation, causes and outcome of endocarditis.
It is the largest study of the infection and looked at 2781 patients from 58 hospitals in 25 countries.
"It's been a very successful study," Murdoch said. "We'd been using data that was 30, 40, 50 years old, so this will really update how we diagnose and treat the disease.
"This study enables us to be much more definitive about the contemporary causes of this serious disease; how to better treat it and reduce the stubbornly high mortality rates," Murdoch said.
Researchers discovered that a quarter of endocarditis patients contracted the infection after being exposed to invasive health care, such as having an IV line, dialysis or an operation.
This finding was relevant with New Zealand's ageing population, who would need more hospital care, he said.
Other factors linking endocarditis with in-hospital deaths were increasing age, pulmonary oedema and other heart-valve complications.
The most common cause of endocarditis is through the bacterium, Staphylococcus aureus.
The research was published this month in the Archives of Internal Medicine.
The New Zealand arm of the study involved hospitals in Auckland, Wellington and Christchurch.
http://www.stuff.co.nz/the-press/news/christchurch/2267436/Heart-valve-illness-studied
The Press
Last updated 05:00 17/03/2009
Christchurch medics are shedding new light on a deadly heart condition that kills up to 40 per cent of sufferers within a year.
Endocarditis is an infection of the heart valve that requires hospitalisation, intravenous antibiotics and, in severe cases, replacement of the infected heart valve.
In Canterbury, there are about 30 new patients with endocarditis each year and an estimated 300 across New Zealand.
However, lead investigator, Professor David Murdoch, of the University of Otago, Christchurch, said mortality rates were lower in New Zealand.
Globally, 18 per cent of people die from endocarditis in hospital and up to 40 per cent will die within a year.
There are also risks of ongoing complications such as stroke, blood clots and heart failure.
The five-year study examined the presentation, causes and outcome of endocarditis.
It is the largest study of the infection and looked at 2781 patients from 58 hospitals in 25 countries.
"It's been a very successful study," Murdoch said. "We'd been using data that was 30, 40, 50 years old, so this will really update how we diagnose and treat the disease.
"This study enables us to be much more definitive about the contemporary causes of this serious disease; how to better treat it and reduce the stubbornly high mortality rates," Murdoch said.
Researchers discovered that a quarter of endocarditis patients contracted the infection after being exposed to invasive health care, such as having an IV line, dialysis or an operation.
This finding was relevant with New Zealand's ageing population, who would need more hospital care, he said.
Other factors linking endocarditis with in-hospital deaths were increasing age, pulmonary oedema and other heart-valve complications.
The most common cause of endocarditis is through the bacterium, Staphylococcus aureus.
The research was published this month in the Archives of Internal Medicine.
The New Zealand arm of the study involved hospitals in Auckland, Wellington and Christchurch.
http://www.stuff.co.nz/the-press/news/christchurch/2267436/Heart-valve-illness-studied